A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...

A recent study suggests that two existing drugs, empagliflozin and an experimental insulin nasal spray, may help enhance ...

For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer's disease. As health reporter Katherine Ward explains, doctors say this marks a ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...